HC Wainwright & Co. Reiterates Neutral on Macrogenics, Maintains $4 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Robert Burns has reiterated a Neutral rating on Macrogenics (NASDAQ:MGNX) and maintained a $4 price target.

August 01, 2024 | 10:17 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. has reiterated a Neutral rating on Macrogenics and maintained a $4 price target, indicating no expected significant short-term price movement.
The reiteration of a Neutral rating and maintenance of the $4 price target suggests that the analyst does not foresee significant changes in the stock's performance in the short term. This typically indicates a stable outlook without major catalysts for upward or downward movement.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100